Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer.
Saved in:
| Title: | Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer. |
|---|---|
| Authors: | Burkhart DL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Morel KL; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wadosky KM; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York., Labbé DP; Division of Urology, Department of Surgery, McGill University and Research Institute of the McGill University Health Centre, Montréal, Québec, Canada., Galbo PM; Department of Cell Biology, Albert Einstein College of Medicine, New York, New York., Dalimov Z; State University of New York at Buffalo, Buffalo, New York., Xu B; Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Ellis L; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts. Leigh_Ellis@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts. |
| Source: | Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2020 Dec; Vol. 13 (12), pp. 979-988. Date of Electronic Publication: 2020 Sep 11. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
